|
MICROSEMI CORPORATION | ||||||||||||
|
Summary of Schedule Reconciling Selected Non-GAAP Financial Measures | ||||||||||||
|
to Comparable GAAP Financial Measures | ||||||||||||
|
(unaudited, in millions, except for per share amounts) | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quarter Ended March 31, 2013 | ||||||||||
|
|
|
GAAP |
|
Non-GAAP Adjustments |
|
Non-GAAP | ||||||
|
Net sales |
|
$ |
235.3 |
|
|
$ |
— |
|
|
$ |
235.3 |
|
|
Gross profit |
|
$ |
133.5 |
|
|
$ |
— |
|
|
$ |
133.5 |
|
|
Operating income (loss) |
|
$ |
11.8 |
|
|
$ |
38.2 |
|
|
$ |
50.0 |
|
|
Net income |
|
$ |
(2.9) |
|
|
$ |
41.8 |
|
|
$ |
38.9 |
|
|
Diluted earnings (loss) per share |
|
$ |
(0.03) |
|
|
$ |
0.46 |
|
|
$ |
0.43 |
|
